
Research Square (Research Square), Journal Year: 2023, Volume and Issue: unknown
Published: Sept. 15, 2023
Language: Английский
Research Square (Research Square), Journal Year: 2023, Volume and Issue: unknown
Published: Sept. 15, 2023
Language: Английский
Biomolecules, Journal Year: 2023, Volume and Issue: 13(6), P. 943 - 943
Published: June 5, 2023
Melatonin is a fascinating molecule that has captured the imagination of many scientists since its discovery in 1958. In recent times, focus changed from investigating natural role as transducer biological time for physiological systems to hypothesized roles virtually all clinical conditions. This goes along with appearance extensive literature claiming (generally) positive benefits high doses melatonin animal models and various situations would not be receptor-mediated. Based on assumption safe, have been administered patients, including elderly children, trials. this review, we critically review corresponding literature, hypotheses acts scavenger molecule, particular mitochondria, by trying only contextualize these interests but also attempting separate wheat chaff (or wishful thinking facts). We conclude most claims remain experimental evidence used promote them limited sometimes flawed. Our will hopefully encourage researchers reflect what can cannot do help move field forward solid basis.
Language: Английский
Citations
37Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15
Published: July 25, 2024
Neurodegenerative diseases constitute a global health issue and major economic burden. They significantly impair both cognitive motor functions, their prevalence is expected to rise due ageing societies continuous population growth. Conventional therapies provide symptomatic relief, nevertheless, disease-modifying treatments that reduce or halt neuron death malfunction are still largely unavailable. Amongst the common hallmarks of neurodegenerative protein aggregation, oxidative stress, neuroinflammation mitochondrial dysfunction. Transcription factor nuclear factor-erythroid 2-related 2 (NRF2) constitutes central regulator cellular defense mechanisms, including regulation antioxidant, anti-inflammatory pathways, making it highly attractive therapeutic target for disease modification in disorders. Here, we describe role NRF2 neurodegeneration, review current pharmacological interventions challenges activating pathway, present alternative approaches modification.
Language: Английский
Citations
9Molecular Neurobiology, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 20, 2025
Language: Английский
Citations
1International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(20), P. 15315 - 15315
Published: Oct. 18, 2023
Ferroptosis is an iron-dependent mode of cell death associated with the occurrence and development age-related neurodegenerative diseases. Currently, there are no effective drugs available to prevent or treat these aging-related Vitamin D (VD) antioxidant immunomodulator, but its relationship ferroptosis in diseases has not been extensively studied. In this study, we aimed investigate role VD learning memory aging mice. To examine whether protects hippocampal neurons, used physiologically active 1,25(OH)2D3. We established models vivo (C57BL/6 mice) vitro (HT22 cells) using D-galactose (D-gal). The results demonstrated that could improve mice aged via use D-gal, it reduced damage neurons. regulate ferroptosis-related proteins (increasing GPX4 expression decreasing ACSL4 ALOX15 protein levels), increasing GSH levels, reducing MDA intracellular mitochondrial ROS as well total iron Fe2+ improving morphology, thereby alleviating Additionally, activated VDR/Nrf2/HO-1 signaling pathway, inhibiting ferroptosis. Notably, when VDR was knocked down, lost ability activate Nrf2. Consequently, Nrf2 decreased protective effect against summary, activates Nrf2/HO-1 pathway through VDR, effectively preventing induced by
Language: Английский
Citations
21Progress in Neurobiology, Journal Year: 2023, Volume and Issue: 231, P. 102539 - 102539
Published: Oct. 12, 2023
Neurodegenerative diseases (NDDs) causing cognitive impairment and dementia are difficult to treat due the lack of understanding primary initiating factors. Meanwhile, major sporadic NDDs share many risk factors exhibit similar pathologies in their early stages, indicating existence common initiation pathways. Glucose hypometabolism associated with oxidative stress is one such primary, shared pathology, a likely cause detrimental disease-associated cascades; targeting this pathology may therefore be an effective preventative strategy for most NDDs. However, its exact trigger remain unclear. Recent research suggests that caused by NADPH oxidase (NOX) activation mechanism among could prove long-sought ubiquitous NDD trigger. We focus on two - Alzheimer's disease (AD) Parkinson's (PD), as well acquired epilepsy which increasingly recognized comorbidity also discuss available data suggesting relevance proposed mechanisms other delve into commonalities these neuroinflammation NOX involvement identify potential therapeutic targets gain deeper underlying causes
Language: Английский
Citations
13Antioxidants, Journal Year: 2024, Volume and Issue: 13(6), P. 696 - 696
Published: June 6, 2024
The transcription factor nuclear erythroid 2-related 2 (Nrf2) represents the master regulator of cellular antioxidant response and plays a critical role in tumorigenesis. This includes preventive effect Nrf2 on cell death through ferroptosis, which an essential mechanism therapy resistance malignant tumors, such as pancreatic ductal adenocarcinoma (PDAC) one most aggressive still incurable tumors. Addressing this issue, we provide overview mediated with particular emphasis its mitochondria organelle responsible for execution ferroptosis. We further outline how deregulated adds to progression PDAC, especially respect ferroptosis anti-cancer drug killing is impaired by resistance. Our review discusses recent approaches inhibition natural synthetic compounds overcome based enhanced Finally, outlook therapeutic strategies combined inducing drugs.
Language: Английский
Citations
5Nano Today, Journal Year: 2024, Volume and Issue: 57, P. 102401 - 102401
Published: July 13, 2024
Language: Английский
Citations
5Neurochemistry International, Journal Year: 2025, Volume and Issue: unknown, P. 105928 - 105928
Published: Jan. 1, 2025
Glutamate-induced neuronal death is associated with neurodegeneration including cerebral ischemia. Several μ-opioid receptor antagonists exhibit a neuroprotective activity and have been considered as potential therapeutic option for neurodegenerative disorders. For the first time, our current study unveiled of selective δ-opioid antagonists. A potent, antagonist naltriben, also known potent TRPM7 agonist, displayed prominent protective effect against glutamate-induced toxicity through opioid receptor-independent, TRPM7-independent mechanisms in HT22 cells. Naltriben activated Nrf2 pathway, alleviated Ca
Language: Английский
Citations
0Pharmaceuticals, Journal Year: 2025, Volume and Issue: 18(1), P. 133 - 133
Published: Jan. 20, 2025
Neuroinflammation is a key factor in the progression of neurodegenerative diseases, driven by dysregulation molecular pathways and activation brain’s immune system, resulting release pro-inflammatory oxidative molecules. This chronic inflammation exacerbated peripheral leukocyte infiltration into central nervous system. Medicinal plants, with their historical use traditional medicine, have emerged as promising candidates to mitigate neuroinflammation offer sustainable alternative for addressing conditions green healthcare framework. review evaluates effects medicinal plants on neuroinflammation, emphasizing mechanisms action, effective dosages, clinical implications, based systematic search databases such PubMed, SCOPUS, Web Science. The findings highlight that like Cleistocalyx nervosum var. paniala, Curcuma longa, Cannabis sativa, Dioscorea nipponica reduce cytokines (TNF-α, IL-6, IL-1β), inhibit enzymes (COX-2 iNOS), activate antioxidant pathways, particularly Nrf2. NF-κB primary pathway inhibited across studies. While anti-inflammatory potential these significant, variability dosages phytochemical compositions limits translation. Here, we are modulators underscoring therapeutic potential. Future research should focus animal models, standardized protocols, safety assessments, integrating advanced methodologies, genetic studies nanotechnology, enhance applicability disease management.
Language: Английский
Citations
0Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 109 - 132
Published: Jan. 1, 2025
Language: Английский
Citations
0